About Rgeno Pharmaceuticals
Rgeno Pharmaceuticals is a Healthcare company. Manufacturing and supplying pharmaceutical products in India. Its Indian entity Rgeno Pharmaceuticals Private Limited reported revenue of βΉ1.6 Lakh. Rgeno Pharmaceuticals offers products and services including RGMOX 1 GM Tablet and G FLAM SP Tablet. Its focus areas include Pharmaceuticals, Drug Manufacturing, Generic Medicines and Medical Supplies.
Company details
Rgeno Pharmaceuticals Pvt. Ltd. is recognized for having built trust among numerous customers through the production of pharmaceutical products using quality materials and advanced technologies that align with industry standards. A commitment to providing high-standard services to retailers and customers is maintained, while adapting to changes in the market. The company is noted for its inventory of tablets, injections, and syrups, which are made available for inquiries, emphasizing reliability and adherence to excellence in operations.
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website rgenopharma.com
- Legal Name Rgeno Pharmaceuticals Pvt. Ltd
- Date of Incorporation 18 Jan, 2018
- Jurisdiction Navi Mumbai, Maharashtra, India
- Indian entity revenue₹1.6 Lakh
FY 2024 · -41% YoY
- Indian entity net profit₹5,545
FY 2024 · 3% margin
- Indian entity EBITDA₹9,843
FY 2024 · 6% margin
Associated legal entities of Rgeno Pharmaceuticals
Rgeno Pharmaceuticals operates through Rgeno Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Rgeno Pharmaceuticals Private Limited CIN U74999MH2018PTC304439 | Active | 18 Jan 2018 | Navi Mumbai, Maharashtra | ₹0.0 Cr | 2 | View details |
Products & Services of Rgeno Pharmaceuticals
Rgeno Pharmaceuticals offers a comprehensive portfolio of products and services, including RGMOX 1 GM Tablet and G FLAM SP Tablet.
RGMOX 1 GM Tablet is manufactured as a pharmaceutical product for health purposes, utilizing quality materials to meet industry standards
G FLAM SP Tablet is produced as another pharmaceutical offering, designed to align with established health requirements
Board of directors of Rgeno Pharmaceuticals Private Limited (Rgeno Pharmaceuticals)
Rgeno Pharmaceuticals Private Limited is the primary company behind Rgeno Pharmaceuticals. The board of Rgeno Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Dilip Kumar, appointed in 2018.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Dilip Kumar DIN 08011563 | Director | 18 Jan 2018 | 8 yrs 10 mo | Rgeno Pharmaceuticals Private Limited |
| Deepak Kumar DIN 08011557 | Director | 18 Jan 2018 | 8 yrs 10 mo | Rgeno Pharmaceuticals Private Limited |
Financials of Rgeno Pharmaceuticals
Figures of Rgeno Pharmaceuticals Private Limited, the primary company behind Rgeno Pharmaceuticals, for FY 2024. Revenue was ₹1.6 Lakh (-41% year on year). Net profit was ₹5,545 (3% margin). EBITDA was ₹9,843 (6% margin). Revenue has grown at a compounded annual rate of -29% over three years and +30% over five years.
- ₹1.6 LakhRevenue · FY 2024 · -41% YoY
- ₹5,545Net profit · 3% margin
- ₹9,843EBITDA · 6% margin
- ₹5 LakhPaid-up capital
- -29%Revenue CAGR, 3 years
- +30%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Rgeno Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Rgeno Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Rgeno Pharmaceuticals
The primary company behind Rgeno Pharmaceuticals, Rgeno Pharmaceuticals Private Limited, reported revenue of βΉ1.6 Lakh for FY 2024, down 41% year on year.
Rgeno Pharmaceuticals Pvt. Ltd. is recognized for having built trust among numerous customers through the production of pharmaceutical products using quality materials and advanced technologies that align with industry standards. A commitment to providing high-standard services to retailers and customers is maintained, while adapting to changes in the market. The company is noted for its inventory of tablets, injections, and syrups, which are made available for inquiries, emphasizing reliability and adherence to excellence in operations.
Rgeno Pharmaceuticals offers RGMOX 1 GM Tablet and G FLAM SP Tablet.
Rgeno Pharmaceuticals operates through Rgeno Pharmaceuticals Private Limited.
The legal entities of Rgeno Pharmaceuticals currently have 2 directors, including Dilip Kumar, Deepak Kumar.
